LATEST NEWS
OUR EXPERTS KEEPING YOU UP TO DATE WITH OUR EVER CHANGING INDUSTRY
Lucius Partners Portfolio Company AerWave Medical, Inc. Announces it Initiated Filing of Regulatory Documents for First in Man Studies
Lucius Partners Portfolio Company AerWave Medical, Inc. Announces it Initiated Filing of Regulatory Documents for First in Man Studies Important step [...]
Lucius Partners Portfolio Company AerWave Medical, Inc. Announces it Has Filed Two New Patent Applications
Lucius Partners Portfolio Company AerWave Medical, Inc. Announces it Has Filed Two New Patent Applications Further Advances IP Portfolio Address Key [...]
Lucius Partners Portfolio Company PD Theranostics, Inc. Signs Letter of Intent to Merge with Fulton Ventures Corp.
Lucius Partners Portfolio Company PD Theranostics, Inc. Signs Letter of Intent to Merge with Fulton Ventures Corp. New York, NY 6 [...]
PD Theranostics, Inc., a Lucius Partners Company, Announces Key License Agreement and Provides Corporate Update
PD Theranostics, Inc., a Lucius Partners Company, Announces Key License Agreement and Provides Corporate Update Licensing Key IP from the Massachusetts [...]
Voltron Therapeutics, a Lucius Partners Company, with the VIC at MGH Announces $5.88 Million Award from U.S. DoD
Voltron Therapeutics, a Lucius Partners Company, with the VIC at MGH Announces $5.88 Million Award from U.S. DoD Award will advance [...]
Lucius Partners Portfolio Company Voltron Therapeutics, Inc Adds Manufacturing Expert to Scientific Advisory Board
Lucius Partners Portfolio Company Voltron Therapeutics, Inc Adds Manufacturing Expert to Scientific Advisory Board Globally recognized manufacturing and product supply expert [...]
Lucius Partners Portfolio Company Voltron Therapeutics Announces Robust Immunogenicity Data: Key Prostate Cancer Target
Lucius Partners Portfolio Company Voltron Therapeutics Announces Robust Immunogenicity Data: Key Prostate Cancer Target Self Assembling Vaccine targets Prostate Stem Cell [...]
Lucius Partners Portfolio Company Voltron Therapeutics, Inc. Announces Sponsored Research Agreement with the Massachusetts General Hospital, Harvard Medical School, to Initiate a Pre-clinical Immuno-Oncology Trial
Lucius Partners Portfolio Company Voltron Therapeutics, Inc. Announces Sponsored Research Agreement with the Massachusetts General Hospital, Harvard Medical School, to Initiate a Pre-clinical Immuno-Oncology Trial [...]
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Poster Presentation at the Military Health System Research Symposium
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Poster Presentation at the Military Health System Research Symposium Poster demonstrates the [...]
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Definitive Proof of Concept Data for its Lead Oncology Candidate (VTX-067) in an HPV Related Tumor Challenge Study
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Definitive Proof of Concept Data for its Lead Oncology Candidate (VTX-067) in an HPV Related Tumor [...]
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Industry Veteran Dr. Tony Hodges has Joined the Company as Senior Scientific Advisor
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Industry Veteran Dr. Tony Hodges has Joined the Company as Senior Scientific Advisor [...]
Voltron Therapeutics, Inc., a Lucius Partners Company, Announces Initiation of Key Preclinical Study of VTX-067 in Immuno-Oncology
Voltron Therapeutics, Inc., a Lucius Partners Company, Announces Initiation of Key Preclinical Study of VTX-067 in Immuno-Oncology Study is designed to [...]
Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company, Announces Industry Veteran Dr. Simon Pedder has Joined the Board of Directors
Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company, Announces Industry Veteran Dr. Simon Pedder has Joined the Board of Directors [...]
Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company Announces Selection of Therapeutic Targets for Immuno-Oncology Program
Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company Announces Selection of Therapeutic Targets for Immuno-Oncology Program Targets selected to target [...]
Voltron Therapeutics, Inc.’s Scientific Co-Founder Dr. Mark C. Poznansky has Guest Essay Published in the New York Times
Voltron Therapeutics, Inc.’s Scientific Co-Founder Dr. Mark C. Poznansky has Guest Essay Published in the New York Times “The Vaccines We [...]
Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. Names Anthony Zook, Former CEO of AstraZeneca North America, Executive Chairman
Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. Names Anthony Zook, Former CEO of AstraZeneca North America, Executive Chairman. From globenewswire.com: Voltron Therapeutics, Inc. today [...]
Voltron Therapeutics, Inc. Announces Positive Data from Animal Testing of Self-Assembling Vaccine in the Fight Against COVID-19
Voltron Therapeutics, Inc. Announces Positive Data from Animal Testing of Self-Assembling Vaccine in the Fight Against COVID-19 From globenewswire.com: Voltron Therapeutics, [...]
Voltron Therapeutics, Inc. Announces Positive Data from Animal Testing of Self-Assembling Vaccine in the Fight Against COVID-19
Voltron Therapeutics, Inc. Announces Positive Data from Animal Testing of Self-Assembling Vaccine in the Fight Against COVID-19 From globenewswire.com: Voltron Therapeutics, Inc. today announced positive [...]
Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. Names Anthony Zook, Former CEO of AstraZeneca North America, Executive Chairman.
Laidlaw Venture Partners Portfolio Company Voltron Therapeutics, Inc. Names Anthony Zook, Former CEO of AstraZeneca North America, Executive Chairman. From globenewswire.com: [...]
Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19
Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19 Animal Trials to Assess the Effect of Novel Vaccine [...]
Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore Strategic Alternatives for its HaloVax™ Subsidiary
Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore Strategic Alternatives for its HaloVax™ Subsidiary Unique, Self-Assembling Vaccine Against COVID-19 is in Animal [...]
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a [...]
Voltron Therapeutics Publishes Letter to Shareholders
Voltron Therapeutics Publishes Letter to Shareholders
Dr. Poznansky is interviewed on Bloomberg Radio
Listen to Dr. Poznanski's interview on Bloomberg Radio and his thoughts on operation "Warp Speed"
Voltron Therapeutics, Inc. Announces Selection of the First of Two Sets of Virus Targeting Peptides for Animal Testing in the Development of a COVID-19 Vaccine
Voltron Therapeutics, Inc. Announces Selection of the First of Two Sets of Virus Targeting Peptides for Animal Testing in the Development of a COVID-19 Vaccine [...]
Dr. Poznansky discuses status and safety requirements of vaccinations for COVID-19
Dr. Poznansky discuses status and safety requirements of vaccinations for COVID-19
Dr. Poznansky discuses timeline and safety for vaccine against COVID-19 on MSNBC
Watch Dr. Poznansky on MSNBC discuses the timeline and safety for a potential vaccine against COVID-19...
Dr. Poznansky on what it takes to develop a vaccine during the coronavirus pandemic
What it takes to make a vaccine during the coronavirus pandemic. A look inside the process for a potential coronavirus vaccine...
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Develop Potential COVID-19 Vaccine
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Develop Potential COVID-19 Vaccine [...]
Hoth, Voltron form Halovax to to find COVID-19 Vaccine
‘It’s an incredibly challenging time’: Hoth, Voltron form Halovax to find COVID-19 vaccine...